Thyroid cancer

Clinical Obstetrics and Gynecology

Volumn 45, Issue 3, 2002, Pages 879-883

  Thorneycroft, Ian H ^a  

^a One Mobile Infirmary Circle   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; CALCITONIN; CARCINOEMBRYONIC ANTIGEN; IODINE 131; LEVOTHYROXINE; THYROGLOBULIN; THYROXINE;

ASPIRATION BIOPSY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; HUMAN; LARYNGOSCOPY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; PREOPERATIVE RADIOTHERAPY; PROGNOSIS; REVIEW; THYROID CANCER; THYROID SCINTISCANNING;

HUMANS; NEOPLASM STAGING; PROGNOSIS; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0036403758     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200209000-00034     Document Type: Review

References (5)

1. Bell RM. Thyroid carcinoma. Surg Clin North Am. 1986;66:13.
2. Lennquist S. The thyroid nodule. Surg Clin North Am. 1987;66:213-232.
3. Gagel RF, Goepfert H, Callender RL. Changing concepts in the pathogenesis and management of thyroid carcinoma. CA Cancer J Clin. 1996;46:261-283.
4. Tan GH, Gharib H. Thyroid incidentalomas: Management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med. 1997;126:226-231.
5. Cohen MS, Arslan N, Dehdashti F, et al. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery. 2001;130:941-946.